IGC Pharma (IGC) Non Operating Income (2014 - 2025)
IGC Pharma (IGC) reported Non Operating Income of $1.1 million for Q3 2025, up 2406.98% year-over-year from $43000.0 in Q3 2024, and up 252.29% quarter-over-quarter from $306000.0 in Q2 2025.
IGC Pharma (IGC) Non Operating Income (2014 - 2025) Analysis & Trends
IGC Pharma (IGC) has 12 years of Non Operating Income data on file, last reported at $1.1 million in Q3 2025.
- Non Operating Income for Q3 2025 came in at $1.1 million, up 2406.98% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.6 million (up 1548.0% YoY), and the FY2026 annual result was $56000.0, down 82.77% from the prior year.
- Non Operating Income climbed to $1.1 million in Q3 2025 per IGC's latest filing, from $306000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $1.1 million in Q3 2025 and troughed at $4000.0 in Q3 2021.
- A 5-year average of $127631.6 and a median of $32000.0 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2025: Non Operating Income slumped 96.16% in 2022, then soared 2971.43% in 2025.
- A 5-year view of Non Operating Income shows it stood at $4000.0 in 2021, then surged by 625.0% to $29000.0 in 2022, then grew by 10.34% to $32000.0 in 2023, then soared by 53.12% to $49000.0 in 2024, then surged by 2100.0% to $1.1 million in 2025.
- Business Quant data shows IGC's Non Operating Income at $1.1 million in Q3 2025, $306000.0 in Q2 2025, and $215000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 9.35 Mn |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 306,000.00 |
| Mar 31, 2025 | 215,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 64,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 29,000.00 |
| Sep 30, 2022 | 46,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 443,000.00 |
| Mar 31, 2021 | 11,000.00 |
| Dec 31, 2020 | 3,000.00 |